Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine + lidocaine versus levobupivacaine + lidocaine for superficial cervical block in carotid endarterectomy
ACTRN12625001240437Phase 4Not yet recruiting
- Sponsor
- University Hospital Center Sestre milosrdnice
- Start
- Dec 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in carotid atheroma (CAS) comparing ropivacaine + lidocaine with levobupivacaine + lidocaine (2 arms). Primary endpoints: Time to onset of sensory block and Duration of sensory block. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
ropivacainelidocainelevobupivacaine
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on ACTRN12625001240437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001240437.